Phillips-Medisize Teams with GlucoModicum to Develop an Innovative Needle-Free Continuous Glucose Monitor
- First-of-its-kind, non-invasive continuous glucose monitor (CGM) was designed leveraging Phillips-Medisize extensive medical device design and development expertise
- Phillips-Medisize's proven experience in human-centered product design, electronics, connectivity, software, manufacturability and regulatory compliance will drive commercialization
HUDSON, WI - Media OutReach – 4 October 2023 - Phillips-Medisize, a Molex company, and a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, invitro diagnostic and medtech devices, has teamed with GlucoModicum, an innovative medtech company based in Finland, to design and eventually commercialize a proprietary non-invasive, wearable device that removes technology and patient-care roadblocks to continuous glucose monitoring (CGM).
















